Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Acasti Pharma Inc
ACST | US
3.22
USD-0.11
-3.30%
ACST | US
About Acasti Pharma Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
3.22
Open
3.27
High
3.39
Low
3.12
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104 an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102 an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101 a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval Canada.
View LessACST | US
Risk
85.0
Sharpe
0.27
Luna's Score
42/100
Recommendation
Sell
Luna says (ACST | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
61.2%1 month
85.0%3 months
67.4%6 months
58.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.56
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.56
Ent. to rev.
5.50
PEG
-
Other Fundamentals
EBITDA
-13.27M
MarketCap
32.65M
MarketCap(USD)
32.65M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-18.56
Short ratio
3.26
Short perc.
1.61
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.48
Range1M
0.94
Range3M
1.37
Volumes: Market Activity
Rel. volume
0.57
Price X volume
68.74K
